Phenominer Database Results (7 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Experiment Notes Record ID Study ID
WF/NHsd percentage of study population developing experimental autoimmune neuritis during a period of time peripheral myelin protein 2 peptide 58-81 (100 ug) and Freund's complete adjuvant (100 ul) de Graaf KL, et al., J Neuroimmunol. 2004 Oct;155(1-2):73-84. peripheral nervous system integrity trait male 98 days-200 days 5 0.0 % ex vivo visual assessment 0.0 0 peripheral nervous system integrity trait 84525 1178
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60 mammary gland integrity trait female 155 days-160 days 50 6.9 null 0.4 2.83 unspecified method 0 3X3 mm diameter or larger 11743 142
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 29 6.3 null 0.5 2.69 necropsy 0.0 0 3X3 mm diameter or larger 70167 143
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 46 7.9 null 0.5 3.39 in vivo visual assessment 0.0 0 70314 653
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Lan H, et al., Genetics 2001 Jan;157(1):331-9 mammary gland integrity trait female 169 days-174 days 21 7.3 null 0.98 4.5 necropsy 0 3X3 mm diameter or larger 11742 141
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12 mammary gland integrity trait female 155 days-160 days 30 8.1 null 0.7 3.83 necropsy 0 3X3 mm diameter or larger 11746 143
WF/NHsd percentage of study population developing experimental autoimmune neuritis during a period of time peripheral nerve myelin (2 mg) and Freund's complete adjuvant (100 ul) de Graaf KL, et al., J Neuroimmunol. 2004 Oct;155(1-2):73-84. peripheral nervous system integrity trait male 98 days-200 days 5 0.0 % ex vivo visual assessment 0.0 0 peripheral nervous system integrity trait 84475 1178